Onkológia 1/2008
ACCES TO INNOVATIVE DRUGS IN ONCOLOGY IN SLOVAKIA – COMPARISON WITH THE WORLD
Mortality on oncological diseases had till the end of 20th century for a long time an increasing trend, from 1999 – 2000 it starts to decrease. After all, survival in selected oncological diseases is raising, but all epidemiological parameters are still worse then in the EU 15 countries and the developed world. It is higly probable, that the improving survival is connected with the use of modern surgical and diagnostic methods, earlier diagnosis and better acces to innovative drugs in Slovakia.
Keywords: oncology, oncological drugs, costs, costs effectivness, survival, availability
